These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2107654)

  • 1. Effects of a dopamine antagonist (metoclopramide) on the release of LH, FSH, TSH and PRL in normal women throughout the menstrual cycle.
    Seki K; Nagata I
    Acta Endocrinol (Copenh); 1990 Feb; 122(2):211-6. PubMed ID: 2107654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sequence of pituitary responses to synthetic luteinizing hormone releasing hormone (LH-RH) throughout the normal menstrual cycle.
    Grimes EM; Thompson IE; Taymor ML
    Acta Endocrinol (Copenh); 1975 Aug; 79(4):625-34. PubMed ID: 1098349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of thyrotropin-releasing hormone stimulation on serum levels of gonadotropins in women during the follicular and luteal phases of the menstrual cycle.
    Colon JM; Lessing JB; Yavetz C; Peyser MR; Ganguly M; Weiss G
    Fertil Steril; 1988 May; 49(5):809-12. PubMed ID: 3129315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of metoclopramide to influence LH, FSH and TSH secretion or their responses to releasing hormones.
    Spitz IM; Trestian S; Cohen H; Arnon N; LeRoith D
    Acta Endocrinol (Copenh); 1979 Dec; 92(4):640-7. PubMed ID: 119396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a dopamine antagonist (metoclopramide) on the release of the adenohypophyseal hormones in amenorrhoeic patients with and without hyperprolactinaemia.
    Seki K; Uesato T; Kato K
    Acta Endocrinol (Copenh); 1982 Oct; 101(2):166-70. PubMed ID: 6814135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dopaminergic inhibition of LH secretion during the menstrual cycle.
    Ropert JF; Quigley ME; Yen SS
    Life Sci; 1984 May; 34(21):2067-73. PubMed ID: 6427547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability and selectivity of anterior pituitary response to dopamine agonists throughout the normal menstrual cycle.
    Kletzky OA; Shangold GA
    Am J Obstet Gynecol; 1986 Feb; 154(2):362-7. PubMed ID: 3080890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous melatonin enhances the TRH-induced prolactin release in normally cycling women: a sex-specific effect.
    Terzolo M; Piovesan A; Osella G; Torta M; Buniva T; Paccotti P; Wierdis T; Angeli A
    Gynecol Endocrinol; 1991 Jun; 5(2):83-94. PubMed ID: 1656706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of naloxone on endogenous opioid regulation of pituitary gonadotropins and prolactin during the menstrual cycle.
    Snowden EU; Khan-Dawood FS; Dawood MY
    J Clin Endocrinol Metab; 1984 Aug; 59(2):298-302. PubMed ID: 6330154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interrelationships between prolactin and thyrotrophin secretion following dopaminergic blockage in patients with mild hyperprolactinaemia without any demonstrable pituitary tumour.
    Spitz IM; Haas M; Trestian S; Zylber-Haran E; Shilo S
    Clin Endocrinol (Oxf); 1983 Sep; 19(3):285-94. PubMed ID: 6414745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressed follicle-stimulating hormone, luteinizing hormone, and prolactin responses to the luteinizing hormone-releasing hormone, thyrotropin-releasing hormone, and metoclopramide test in endurance runners in the hard-training season.
    Ronkainen H
    Fertil Steril; 1985 Dec; 44(6):755-9. PubMed ID: 3935485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human inhibin-A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in rhesus monkeys.
    Molskness TA; Woodruff TK; Hess DL; Dahl KD; Stouffer RL
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4002-6. PubMed ID: 8923851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
    Quigley ME; Sheehan KL; Casper RF; Yen SS
    J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a superactive luteinizing hormone-releasing factor agonist on gonadotropin and ovarian function during the menstrual cycle.
    Sheehan KL; Casper RF; Yen SS
    Am J Obstet Gynecol; 1979 Nov; 135(6):759-63. PubMed ID: 386801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the correlation of luteinizing hormone-releasing hormone, luteinizing hormone, follicle-stimulating hormone, and prolactin levels in plasma of women with normal menstrual cycles.
    Aksel S
    Am J Obstet Gynecol; 1981 Oct; 141(4):362-7. PubMed ID: 6792924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulsatile secretion of gonadotropins and prolactin during the follicular and luteal phases of the menstrual cycle: analysis of instantaneous secretion rate and secretory concomitance.
    Inaudi P; Reymond MJ; Rey F; Genazzani AD; Lemarchand-Béraud T
    Fertil Steril; 1992 Jul; 58(1):51-9. PubMed ID: 1624023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of circulating concentrations of gonadotropins and ovarian hormones throughout the menstrual cycle in the bonnet monkey: role of inhibin A in the regulation of follicle-stimulating hormone secretion.
    Suresh PS; Medhamurthy R
    Am J Primatol; 2009 Oct; 71(10):817-24. PubMed ID: 19452529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of altered dopaminergic modulation of Prl, LH, FSH, GH and TSH secretion during chronic partial dopamine receptor blockade in normal women.
    Hagen C; Andersen AN; Djursing H
    Acta Endocrinol (Copenh); 1984 May; 106(1):1-7. PubMed ID: 6428112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible altered dopaminergic modulation of pituitary function in normal-menstruating women with insulin dependent diabetes mellitus (IDDM).
    Djursing H; Carstensen L; Hagen C; Andersen AN
    Acta Endocrinol (Copenh); 1984 Dec; 107(4):450-5. PubMed ID: 6440390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of altered dopaminergic modulation of Prl, LH and TSH secretion in patients with normoprolactinaemic amenorrhoea.
    Hagen C; Petersen K; Djursing H; Andersen AN
    Acta Endocrinol (Copenh); 1984 May; 106(1):8-14. PubMed ID: 6428118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.